Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 161   

Articles published

MRK 58.53 -0.01 (-0.01%)
price chart
BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead
Pharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE). Meanwhile biotech investors ...
Earnings Whispers - Merck & Co., Inc. (MRK) To Report Q2 Earnings Today  Bidness ETC
Merck & Co., Inc. (MRK) Releases FY15 Earnings Guidance  Junior College
Merck & Co., Inc. (MRK) Issues FY15 Earnings Guidance
Merck & Co. logo Merck & Co., Inc. (NYSE:MRK) updated its FY15 earnings guidance on Tuesday. The company provided EPS guidance of $3.45-3.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.44, MarketBeat.
Merck & Co. Lifted to Strong-Buy at Vetr Inc. (MRK)  Watch List News
Zacks Rating on Merck & Company, Inc.
As much as 13 analysts have advised buy on Merck & Company, Inc. (NYSE:MRK) with an average broker rating of 2.08. Research Analysts at Zacks has the shares a rating of 3, which implies that the firms recommendation is Neutral on the company.
"The expansion of this ongoing collaboration with Ablynx allows us to increase our ability to evaluate the potential of more immune checkpoint targets for the treatment of cancer.
Merck & Co., Inc. - Product Pipeline Review - 2015
This report provides comprehensive information on the current therapeutic developmental pipeline of Merck & Co., Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...
Active Stocks in Review: Merck & Co. Inc. (NYSE:MRK), Magnum Hunter Resources ...
Merck & Co., known as MSD outside the United States and Canada, recently declared that Pamela J. Craig, stepped down chief financial officer of Accenture, and Dr.
Merck & Co. Inc. (MRK) Closes 1.77% Up on the Day for July 29
Dow Jones component Merck & Co. Inc. (MRK) saw its stock move 1.77% to $58.54, representing a per-share move of $1.02, on volume of 12.62 million shares for Wednesday.
Active Stocks Trader's Buzzers: Merck & Co. Inc. (NYSE:MRK), MetLife, Inc ...
Merck & Co., known as MSD outside the United States and Canada, declared that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of the ...
Allergan PLC On A Roll; Buys Merck & Co. Migraine Drug Rights
Allergan PLC (NYSE:AGN) announced on Tuesday it has entered into an agreement with Merck & Co., Inc. (NYSE:MRK), under which it would acquire exclusive global rights to two of Merck's migraine drugs currently in experimental stages, MK-1602 and ...
Merck & Co. Inc. (NYSE:MRK) and Allergan plc (AGN) Signs Into an ...  StreetWise Report
Merck & Co., Inc. (NYSE:MRK) Sells Its Migraine Drugs To Allergan PLC ...  USMarketsDaily (blog)
Shares of Merck & Company, Inc. (NYSE:MRK) Sees Large Inflow of Net Money Flow
Merck & Company, Inc. (NYSE:MRK) had a weak trading session and its shares were last down at $57.41, down -0.66% or -1.14 points.